Schonfeld Strategic Advisors LLC Protara Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.15 - $7.76 $147,323 - $185,890
-23,955 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$6.38 - $9.3 $3,190 - $4,650
-500 Reduced 2.04%
23,955 $166,000
Q2 2021

Aug 16, 2021
BUY
$8.68 - $16.99 $8,680 - $16,990
1,000 Added 4.26%
24,455 $238,000
Q1 2021

May 17, 2021
BUY
$13.75 - $23.86 $322,506 - $559,636
23,455 New
23,455 $371,000

Others Institutions Holding TARA

# of Institutions
39
Shares Held
10.7M
Call Options Held
9K
Put Options Held
1.8K
View Full List

About Protara Therapeutics, Inc.

TARA Quotes by TradingView
  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $62.1M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email